Issues associated with upscaling exosome production for therapeutic use may be overcome through utilizing artificial exosomes. Cell-derived mimetic nanovesicles (M-NVs) are a potentially...
Read More »Upcoming Webinar – Manufacturing and Characterization of Therapeutic Exosomes
The era of using extracellular vesicles (EVs) and exosomes for regenerative medicine applications in the clinic is here. The team at Capricor Therapeutics, Inc. utilized a cardiosphere-derived stem-like cell culturing process to manufacture secreted EVs present in conditioned medium for ...
Read More »Capricor Therapeutics Awarded $2.4 Million from DoD for Process Development on Therapeutic Exosomes
Capricor Therapeutics, Inc. a clinical-stage biotechnology company developing biological therapies for cardiac and other serious medical conditions, today announced that the U.S. Department of Defense (DoD) has awarded the company a grant1 in the amount of approximately $2.4 million to ...
Read More »